Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.

Iris Dotan*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

In the last decade, new serologic markers have been identified, and attempts to delineate their potential roles in inflammatory bowel disease diagnosis, determination of prognosis and identification of apparently healthy subjects at risk have significantly increased our knowledge. In this review, the major serologic markers will be described, focusing on their common features as a group. It is predicted that within the next 5 years, panels of antibodies will prove to have a significant impact on disease diagnosis and stratification, as well as on the identification of populations at risk and the prediction of response to treatment. Thus, it is expected that they will become useful clinical tools that will enable an improved, 'tailored' approach to inflammatory bowel disease patients.

Original languageEnglish
Pages (from-to)265-274
Number of pages10
JournalExpert Review of Gastroenterology and Hepatology
Volume1
Issue number2
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.'. Together they form a unique fingerprint.

Cite this